TY - JOUR
T1 - Quality of life and secondary outcomes for open versus robot-assisted radical cystectomy
T2 - a double-blinded, randomised feasibility trial
AU - Vejlgaard, Maja
AU - Maibom, Sophia Liff
AU - Joensen, Ulla Nordström
AU - Thind, Peter Ole
AU - Rohrsted, Malene
AU - Aasvang, Eske Kvanner
AU - Kehlet, Henrik
AU - Røder, Martin Andreas
N1 - © 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2022/7
Y1 - 2022/7
N2 - PURPOSE: This study aims to examine quality of life (QoL) before and after radical cystectomy (RC) and compare robot-assisted laparoscopy with intracorporeal urinary diversion (iRARC) to open radical cystectomy (ORC).METHODS: This study is a predefined secondary analysis of a single-centre, double-blinded, randomised feasibility trial. Fifty patients were randomly assigned to iRARC with ileal conduit (n = 25) or ORC with ileal conduit (n = 25). Patients were followed 90 days postoperatively. The primary outcome was patient-reported QoL using the EORTC Cancer-30 and muscle-invasive bladder cancer BLM-30 QoL questionnaires before and after RC. Differences between randomisation arms as well as changes over time were evaluated. Secondary outcomes included 30- and 90 day complication rates, 90 day readmission rates, and 90 day days-alive-and-out-of-hospital and their relationship to QoL.RESULTS: All patients underwent the allocated treatment. We found no difference in QoL, complication rates, readmission rates, and days-alive-and-out-of-hospital between randomisation arms. An overall improvement in QoL was found in the following domains: future perspectives, emotional functioning, and social functioning. Sexual functioning worsened postoperatively. There was no association between having experienced a major complication or lengthy hospitalisation and worse postoperative QoL.CONCLUSION: The QoL does not appear to depend on surgical technique. Apart from sexual functioning, patients report stable or improved QoL within the first 90 postoperative days.
AB - PURPOSE: This study aims to examine quality of life (QoL) before and after radical cystectomy (RC) and compare robot-assisted laparoscopy with intracorporeal urinary diversion (iRARC) to open radical cystectomy (ORC).METHODS: This study is a predefined secondary analysis of a single-centre, double-blinded, randomised feasibility trial. Fifty patients were randomly assigned to iRARC with ileal conduit (n = 25) or ORC with ileal conduit (n = 25). Patients were followed 90 days postoperatively. The primary outcome was patient-reported QoL using the EORTC Cancer-30 and muscle-invasive bladder cancer BLM-30 QoL questionnaires before and after RC. Differences between randomisation arms as well as changes over time were evaluated. Secondary outcomes included 30- and 90 day complication rates, 90 day readmission rates, and 90 day days-alive-and-out-of-hospital and their relationship to QoL.RESULTS: All patients underwent the allocated treatment. We found no difference in QoL, complication rates, readmission rates, and days-alive-and-out-of-hospital between randomisation arms. An overall improvement in QoL was found in the following domains: future perspectives, emotional functioning, and social functioning. Sexual functioning worsened postoperatively. There was no association between having experienced a major complication or lengthy hospitalisation and worse postoperative QoL.CONCLUSION: The QoL does not appear to depend on surgical technique. Apart from sexual functioning, patients report stable or improved QoL within the first 90 postoperative days.
KW - Cystectomy/methods
KW - Feasibility Studies
KW - Humans
KW - Postoperative Complications/etiology
KW - Quality of Life
KW - Robotic Surgical Procedures/methods
KW - Robotics
KW - Treatment Outcome
KW - Urinary Bladder Neoplasms/etiology
KW - Urinary Diversion/methods
KW - Bladder cancer
KW - Quality of life
KW - Robotic surgery
KW - Randomised controlled trial
KW - Patient-reported outcomes
KW - Radical cystectomy
UR - http://www.scopus.com/inward/record.url?scp=85130475232&partnerID=8YFLogxK
U2 - 10.1007/s00345-022-04029-9
DO - 10.1007/s00345-022-04029-9
M3 - Journal article
C2 - 35590011
VL - 40
SP - 1669
EP - 1677
JO - World Journal of Urology
JF - World Journal of Urology
SN - 0724-4983
IS - 7
ER -